Takeda

Image of a neon sign with the word no lit up next to an unlit yes
Biotech

FDA hits Zealand Pharma's Gattex challenger with CRL

In the FDA’s complete response letter, the agency recommended another clinical trial to provide more data for glepaglutide’s efficacy and safety.
Gabrielle Masson Dec 19, 2024 4:22pm
Sketch of lungs

Roivant’s midstage asset fails to show benefit in lung disease

Dec 3, 2024 10:32am
Photo of a final puzzle piece about to fit into a puzzle

Takeda pays Keros $200M upfront for rival to BMS' Reblozyl

Dec 3, 2024 7:30am
slow economic growth

Takeda stops phase 2 post-anesthesia trial over slow enrollment

Oct 31, 2024 5:29am
Stock exchange concept

Ironwood makes further bid for $1B GI drug with subgroup data

Oct 28, 2024 12:33pm
Deal terminate tear up end deal scrap

Takeda axes Huntington’s pact, freeing Wave to pursue partners

Oct 16, 2024 8:07am